The Impact of Distractions on Intracortical Brain-Computer Interface Control of a Robotic Arm

Michael D. Guthrie; Angelica J. Herrera; John E. Downey; Lucas J. Brane; Michael L. Boninger; Jennifer L. Collinger

doi:10.1101/2021.01.28.21250556

Abstract

This was an investigational device observational trial with the objective to evaluate the impact of distractions on intracortical brain-computer interface (BCI) performance. Two individuals with tetraplegia had microelectrode arrays implanted into their motor cortex for trials of intracortical BCI safety and performance. The primary task was moving a robotic arm between two targets as quickly as possible, performed alone and with various secondary distraction conditions. Primary outcomes included targets acquired, path efficiency, and subjective difficulty. There was no difference in the number of targets acquired for either subject with or without distractions. Median path efficiency was similar across all conditions (range: 0.766-0.846) except the motor distraction for Subject P2, where the median path efficiency dropped to 0.675 (p = 0.033, Mann-Whitney U test). Both subjects rated the overall difficulty of the task with and without distractions as low. Overall, intracortical BCI performance was robust to various distractions.

Competing Interest Statement

This material was presented as a poster at the AAPM&R Annual Assembly in San Antonio, Texas to conference attendees in November 2019. This work was supported by the Defense Advanced Research Projects Agency (DARPA) and Space and Naval Warfare Systems Center Pacific (SSC Pacific) under Contract No. N66001-16-C-4051 and the Revolutionizing Prosthetics program under Contract No. N66001-10-C-4056. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of DARPA, SSC Pacific or the United States Government. The material and effort contributed by AH is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. 1747452. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the view of the National Science Foundation. There are no other relevant financial conflicts of interest to report outside the current work.

Clinical Trial

NCT01364480 and NCT01894802

Funding Statement

This work was supported by the Defense Advanced Research Projects Agency (DARPA) and Space and Naval Warfare Systems Center Pacific (SSC Pacific) under Contract No. N66001-16-C-4051 and the Revolutionizing Prosthetics program under Contract No. N66001-10-C-4056. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of DARPA, SSC Pacific or the United States Government. The material and effort contributed by AH is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. 1747452. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the view of the National Science Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Two participants completed this study as a part of a clinical trial conducted under Investigational Device Exemptions granted by the United States Food and Drug Administration and registered at clinicaltrials.gov (NCT01364480 and NCT01894802). Informed consent was obtained from both participants prior to the completion of any study-related procedures. All procedures followed protocol and accord with the ethical standards the Space and Naval Warfare System Center Pacific. Ethical approval was granted by the University of Pittsburgh Institutional Review Board.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes